Alpa Laboratories Limited (BOM:532878)

Market Cap	1.28B -44.0%
Revenue (ttm)	1.14B +18.9%
Net Income	116.09M -53.9%
EPS	5.52 -53.8%
Shares Out	n/a
PE Ratio	11.03
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	758
Average Volume	4,442
Open	61.00
Previous Close	64.67
Day's Range	59.81 - 62.61
52-Week Range	55.10 - 124.88
Beta	n/a
RSI	39.11
Earnings Date	May 26, 2026

About Alpa Laboratories

Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It provides formulations that address various therapeutic segments. The company was incorporated in 1988 and is based in Indore, India.

• Industry: Pharmaceutical Preparations
• Founded: 1988
• Employees: 453
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532878

Financial Performance

In fiscal year 2025, Alpa Laboratories's revenue was 1.12 billion, an increase of 3.41% compared to the previous year's 1.09 billion. Earnings were 195.03 million, an increase of 16.25%.